<DOC>
	<DOC>NCT01053559</DOC>
	<brief_summary>Wireless Capsule Endoscopy has been the most reliable diagnostic standard for small bowel Crohn's disease. Endoscopic healing is an important endpoint to measure response to treatment.</brief_summary>
	<brief_title>Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Adults aged 1870 with confirmed Crohn's disease that includes small bowel disease Moderately to severely active disease (CDAI score &gt;220 and &lt; 450) Stable doses of steroids, 5ASA, antibiotics, Immunosuppressants Any and all contraindications to the use of certolizumab pegol (including but not limited to hepatitis, infection, abscess, malignancy, congestive heart failure [CHF], cytopenia) Small bowel obstruction, stricture, or any contraindication for capsule endoscopy Previous treatment with certolizumab pegol Are pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Crohn's</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
</DOC>